Log In
BCIQ
Print this Print this
 

DEP-cabazitaxel

  Manage Alerts
Collapse Summary General Information
Company Starpharma Holdings Ltd.
DescriptionDendrimer-enhanced, water soluble formulation of cabazitaxel, a taxane derivative
Molecular Target Tubulin
Mechanism of ActionMicrotubule stabilization
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationBreast cancer
Indication DetailsTreat breast cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today